Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DiGeorge syndrome, and more widely, the CATCH 22 syndrome, are associated with microdeletions in chromosomal region 22q11.2. Additionally we are shipping DGCR6 Proteins (7) and many more products for this protein.
Showing 10 out of 40 products:
the frequency of a recurrent small 22q11.2 deletion encompassing PRODH (show PRODH Antibodies) and the neighboring DGCR6 gene in three case-control studies, was studied.
Further studies are now needed to test the usefulness of DGCR6 and DGCR6L (show DGCR6L Antibodies) expression and alterations in the epigenome at these loci in predicting childhood anxiety and associated adult-onset pathologies in 22q11DS subjects.
GABAB1 (show GABBR1 Antibodies) subunits interact with DGCR6 in the endoplasmic reticulum prior to their recruitment into functional GABAB receptors.
Genetic variation at the 22q11 PRODH2 (show PRODH Antibodies)/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia
A compelling genetic hypothesis for a complex disease: PRODH2 (show PRODH Antibodies)/DGCR6 variation leads to schizophrenia susceptibility.
DiGeorge syndrome, and more widely, the CATCH 22 syndrome, are associated with microdeletions in chromosomal region 22q11.2. The product of this gene shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ cell development, and with the gamma-1 subunit of human laminin. This gene is a candidate for involvement in DiGeorge syndrome pathology and in schizophrenia.
DiGeorge syndrome critical region gene 6
, hypothetical protein LOC494718
, diGeorge syndrome critical region 6 homolog
, protein DGCR6
, DiGeorge syndrome critical region protein 6
, DiGeorge syndrome chromosome region 6